BRD2 and serous adenocarcinoma: We observed from Figure 9f that change in the expression of RARRES3 is significantly up-regulated (** p-value < 0.001) in high-grade serous carcinoma compared to NAT and metastatic serous carcinoma (* p-value < 0.05).